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Protein phosphatase 2A (PP2A) is an important ser-
ine/threonine phosphatase that plays a role in many
biological processes. Reversible carboxyl methyla-
tion of the PP2A catalytic subunit is an essential
regulatorymechanism for its function. Demethylation
and negative regulation of PP2A is mediated by
a PP2A-specific methylesterase PME-1, which is
conserved from yeast to humans. However, the
underlying mechanism of PME-1 function remains
enigmatic. Here we report the crystal structures of
PME-1 by itself and in complex with a PP2A heterodi-
meric core enzyme. The structures reveal that PME-1
directly binds to the active site of PP2A and that this
interaction results in the activation of PME-1 by rear-
ranging the catalytic triad into an active conforma-
tion. Strikingly, these interactions also lead to inacti-
vation of PP2A by evicting the manganese ions that
are required for the phosphatase activity of PP2A.
These observations identify a dual role of PME-1
that regulates PP2A activation, methylation, and
holoenzyme assembly in cells.
INTRODUCTION
Protein phosphatase 2A (PP2A) is a major serine/threonine phos-
phatase with complex compositions and is involved in many
essential aspects of cellular function (Janssens and Goris,
2001; Lechward et al., 2001; Virshup, 2000; Yu, 2007). Deregula-
tion of PP2A has been linked to many debilitating diseases such
as cancer (Arroyo and Hahn, 2005; Janssens et al., 2005; Schon-
thal, 2001; Van Hoof and Goris, 2004) and Alzheimer’s disease
(Liu et al., 2005; Sontag et al., 2004, 2007; Vafai and Stock,
2002). The heterodimeric PP2A core enzyme consists of a 36
kDa catalytic subunit, or C subunit, and a 65 kDa scaffold subunit,
or A subunit. To gain full activity toward specific substrates, the
PP2A core enzyme associates with a variable regulatory subunit
to form a heterotrimeric holoenzyme. The regulatory subunits are
divided into four structurally distinct families, B (B55 or PR55), B0
(B56 or PR61), B00 (PR48, PR72, and PR130), and B00 0 (PR93/
PR110) (Janssens and Goris, 2001; Lechward et al., 2001;154 Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc.Virshup, 2000; Yu et al., 2001). Despite significant progress in
the last decade, many essential aspects of PP2A regulation
remain poorly understood.
Reversible methylation of the PP2Acoreenzyme isaconserved
and essential regulatory mechanism (Lee et al., 1996; Lee and
Stock, 1993; Xie and Clarke, 1993, 1994a, 1994b). Methylation
of the carboxy-terminal Leu309 in a conserved TPDYFL309 motif
of the C subunit has been shown to enhance the affinity of the
PP2A core enzyme for some, but not all, regulatory subunits (Ike-
hara et al., 2007; Ogris et al., 1997; Tolstykh et al., 2000; Wei et al.,
2001; Xing et al., 2006; Xu et al., 2006). Intriguingly, changes in
this peptide motif also affected interaction of the C subunit with
the a4 protein, presumably through alteration of methylation
(Chung et al., 1999), and led to a complex with distinct substrate
specificity that is essential for cell survival (Chung et al., 1999;
Kong et al., 2004). Thus changes in PP2A methylation appear
to regulate formation of PP2A complexes and consequently shift
the specificity of PP2A phosphatase activity in cells (Mumby,
2001). Supporting this notion, blockade of PP2A methylation
in yeast caused a set of phenotypes that are consistent with
decreased formation of PP2A holoenzymes (Wu et al., 2000).
Reversible methylation of PP2A is catalyzed by two highly con-
served enzymes, a 38 kDa PP2A-specific leucine carboxyl meth-
yltransferase (LCMT1) (De Baere et al., 1999; Lee and Stock,
1993) and a 42 kDa PP2A-specific methylesterase (PME-1)(Lee
et al., 1996). PME-1 catalyzes removal of the methyl group,
thus reversing the activity of LCMT1 (Lee et al., 1996). Overex-
pression of PP2A methylesterase caused phenotypes similar to
those associated with loss of the methyltransferase gene (Wu
et al., 2000). It had also been demonstrated that methylation
levels of PP2A changed during the cell cycle, suggesting a critical
role of methylation in cell-cycle regulation (Janssens and Goris,
2001; Lee and Pallas, 2007; Turowski et al., 1995).
Recent evidence hints a broader role for PME-1 than just hy-
drolysis of a methylester bond. PME-1 was found to be associ-
ated with two inactive mutants of PP2A (Ogris et al., 1999). A por-
tion of cellular PP2A, which remained stably bound to PME-1,
was found to be inactive (Longin et al., 2004); interestingly, this
inactive portion of PP2A could be reactivated by PP2A phospha-
tase activator (PTPA) but not by LCMT1, ruling out the possibility
that inactivation was solely caused by demethylation (Longin
et al., 2004). These observations suggest that PME-1 might
somehow sequester an inactive portion of PP2A. Surprisingly,
however, the phosphatase activity of the reactivated PP2A was
no longer subject to inhibition by PME-1 (Longin et al., 2004). At
present, the underlying molecular mechanisms of the interplay
between PME-1 and PP2A remain largely unknown.
To understand the regulation of PP2A, we have elucidated the
crystal structures of PME-1 by itself and in complex with the
PP2A core enzyme. Our studies reveal that binding of PME-1
to PP2A results in two opposing consequences: activation of
PME-1 through structural rearrangement and inactivation of
PP2A through removal of catalytic metal atoms. The dual role
of PME-1 likely couples methylation of PP2A with its activation
and holoenzyme assembly.
RESULTS
Structure of PME-1
We first sought to determine the crystal structure of PME-1. De-
spite rigorous effort, the full-length PME-1 failed to crystallize,
Figure 1. Structure of the PP2A-Specific
Methyl Esterase-1
(A) Structure of PP2A-Specific Methyl Esterase-1
(PME-1) in stereo. The core structural elements
are colored cyan and the cap domain in orange.
The catalytic residue Ser156 is labeled.
(B) Sequence alignment of PME-1 from human,
frog, fruit fly, worm, and yeast. Secondary struc-
tural elements are indicated above the alignment.
likely due to the flexible amino-terminal
sequences and an internal Glu-rich loop.
Removal of these flexible moieties by lim-
ited proteolysis generated a core enzyme
that exhibited a similar activity to the
full-length PME-1 (data not shown). We
obtained crystals of this PME-1 core
enzyme. The structure was determined
by selenomethionine multiwavelength
anomalous dispersion (MAD) and refined
to 2.1 A˚ resolution (Figure 1 and Table 1).
To our knowledge, PME-1 represents
the first structure of a eukaryotic protein
methylesterase. The overall structure of
the PME-1 core enzyme belongs to the
a/b hydroxylase superfamily. The a/b
fold contains a central, 9-stranded
b sheet, surrounded by two a helices on
one side (a1 and a10) and four a helices
on the other (a2, a3, a8, and a9) (Figure 1).
The putative catalytic residue Ser156,
from the conserved motif GxSxxG, is
located at the turn between strand b6
and helix a3. Four additional a helices
form a cap domain above Ser156. The ac-
tive site pocket is located between the
cap domain and the a/b fold (Figure 1A).
In the absence of PP2A, the active site
of PME-1 appears to exist in an inactive
conformation that may not support catalysis because Ser156 is
not within hydrogen bond distance of any histidine residue. Sup-
porting this structural observation, prior treatment of PME-1 with
PMSF, a serine protease inhibitor, did not result in any detectable
reduction of methylesterase activity toward the PP2A core en-
zyme. In addition, PME-1 does not bind to and exhibits no detect-
able methylesterase activity toward a carboxyl-methylated pep-
tide TPDYFL309 (Lee et al., 1996). Collectively, these observations
suggest that PME-1 must undergo an activation process, which
is likely mediated by binding to the PP2A core enzyme.
Structure of the PP2A–PME-1 Heterotrimeric Complex
Despite extensive effort, a heterotrimeric complex between
PME-1 and the PP2A core enzyme eluded crystallization. This
was likely due to the flexible nature of the A subunit, a HEAT
repeat protein that is known for heterogeneous conformations
(Chen et al., 2007; Cho et al., 2007; Cho and Xu, 2006; GrovesCell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc. 155
Table 1. Crystallographic Data and Refinement
Crystal Data and Refinement
Crystal PME-1 PME-1 PME-1 PME-1 PP2A–PME-1
Data set Native SeMet SeMet SeMet Native
Peak Inflection Remote
Wavelength (A˚) 1.1000 0.9791 0.9794 0.9641 1.0809
Resolution (A˚) 502.0 502.6 502.6 502.6 502.7
Outer shell (A˚) 2.072.00 2.702.60 2.702.60 2.702.60 2.802.70
No. observations 106972 81583 81605 81394 83552
No. unique reflections 25077 11458 11465 11460 22897
Redundancy 4.3 7.1 7.1 7.1 3.6
Rsym
a 0.074 (0.293) 0.123 (0.329) 0.125 (0.409) 0.122 (0.359) 0.111 (0.477)
Completeness (%) 99.5 (97.3) 99.3 (99.9) 99.3 (99.9) 99.3 (100.0) 98.3 (89.4)
Phasing
Phasing power (ano/iso) 1.03/1.23 0.91/ 0.68/1.42
Rcullis (ano/iso) 0.82/0.58 0.85/ 0.90/0.57
Figure of merit 0.62
Refinement
Resolution (A˚) 502.0 502.8
No. reflections (free) 24574 (1191) 19235 (1018)
Completeness (%) 94.9 98.6
R factor (%)b 18.2 19.5
Rfree (%)
b 21.9 26.4
No. atoms (waters) 2562 (283) 6507 (62)
rmsd bond lengths (A˚)c 0.006 0.007
rmsd bond angles ()c 1.25 1.09
rmsd B factors (A˚2)d 2.9 0.43
Ramachandran plot
Most favored (%) 93.3 89.3
Additional (%) 5.9 9.7
Generous (%) 0.4 0.6
Disallowed (%) 0.4 0.4
a Rsym = ShSi j Ih,i  Ih j / ShSi Ih,i , where Ih is the mean intensity of the i observations of symmetry-related reflections of h.
b R =
P j Fobs  Fcalc j /
P
Fobs, where Fobs = FP, and Fcalc is the calculated protein structure factor from the atomic model (Rfree was calculated with 5%
of the observed reflections).
c rmsd (root-mean-square deviation) in bond lengths and angles are the deviations from ideal values.
d rmsd variation in B factors across bonded atoms, with the value for PP2A–PME-1 being the residual after TLS refinement.et al., 1999; Xing et al., 2006; Xu et al., 2006). To alleviate this
problem, we progressively deleted the amino-terminal HEAT
repeats that are dispensable for binding to the C subunit and
PME-1 (Ruediger et al., 1992, 1994; Xing et al., 2006). One specific
variant of the A subunit, containing HEAT repeats 1 and 11–15
(ADN), formed a stable heterotrimeric complex with the C subunit
and PME-1. The methylesterase activity of PME-1 on the PP2A
core enzyme involving the ADN variant was nearly identical to
that on the PP2A core enzyme involving the full-length A subunit
(Figure S1 available online). This result suggests that deletion of
HEAT repeats 2–10 in the A subunit has no detectable impact on
the interaction between PME-1 and the PP2A core enzyme. The
PP2A core enzyme involving ADN was first methylated by
LCMT1 and then incubated with the catalytic mutant of PME-1
(S156A) to reconstitute a heterotrimeric PP2A–PME-1 complex.
The heterotrimeric complex was crystallized and the structure156 Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc.was determined by molecular replacement at 2.8 A˚ resolution
(Table 1 and Figure 2).
The structure of the PP2A–PME-1 complex showed that PME-1
binds exclusively to the C subunit of the PP2A core enzyme
(Figure 2A). Structural alignment of the PP2A–PME-1 complex
with the PP2A core enzyme indicates that PME-1 makes no
direct interactions with the A subunit (Figure 2B). As previously
observed (Xing et al., 2006), the C subunit sits on the ridge of
HEAT repeats 11–15 in the A subunit (Figure 2A). Inclusion of
HEAT repeat 1 in the ADN subunit proved to be essential for its
solubility and crystallization of the heterotrimeric complex. In
the crystals, HEAT repeat 1 stacks against HEAT repeat 11 to in-
sulate the hydrophobic surfaces in both repeats. PME-1 binds to
the structural elements surrounding the active site of the C sub-
unit. This arrangement creates an extended, linear architecture,
with a height of approximately 100 A˚ (Figure 2A).
The active site pocket of PME-1 is located close to the C
subunit, with an orientation that is conducive to binding by the
carboxyl-methylated peptide from the C subunit. In the structure,
the carboxy-terminal six amino acids T304PDYFL309 of the C sub-
unit are placed in the active site pocket of PME-1 (Figure 2C). The
flexible sequences spanning Pro293–Thr304 are disordered in
the crystals and have no electron density. Pro293 is separated
from Thr304 by approximately 30 A˚ (Figure 2A); the 11 peptide
bonds absent in the structure between these two residues could
reach a distance of as much as 36 A˚ in an extended conformation.
Interface between PME-1 and the C Subunit
PME-1 binds directly to the active site of the C subunit. These
two proteins stack closely against each other, creating an
S-shaped interface (Figure 3A). This interface is dominated by
hydrogen bonds (H-bonds), which are buttressed by additional
van der Waals contacts. Together, these interactions result in
the burial of approximately 1800 A˚2 exposed surface area. Res-
idues from helix a9 of PME-1, and to a lesser extent helix a10,
mediate these interactions.
Examination of the interface revealed three networks of H-
bonds (Figure 3B). In the center of the interface, Arg214 of the
C subunit donates two intermolecular H-bonds, to the carbonyl
oxygen atoms of residues 334 and 335 in PME-1, and two intra-
Figure 2. Structure of PME-1 Bound to the
PP2A Core Enzyme
(A) Structure of the PP2A–PME-1 complex in two
views related by a vertical rotation of 90 degrees.
The scaffold and catalytic subunits are colored
green and blue, respectively. PME-1 is shown in
yellow. The carboxy-terminal peptide is high-
lighted in magenta. The coloring scheme is pre-
served in Figures 3–5.
(B) Structure overlay of the PP2A–PME-1 complex
and the PP2A core enzyme. The A and C subunits
of the PP2A core enzyme are colored pink and
cyan, respectively. This analysis indicates that
PME-1 does not directly bind to the A subunit.
(C) A slice of the surface representation of PME-1
to show the recognition of the carboxy-terminal
peptide of the C subunit. Leu309 is labeled.
molecular H-bonds, one to Asp202 and
the other to carbonyl oxygen of residue
241 in the C subunit. These interactions
are strengthened by two additional inter-
molecular H-bonds between carbonyl
oxygens of residues 335/336 in PME-1
and amide nitrogens of residues 243/
242 in the C subunit. These H-bonds are
stabilized by a patch of van der Waals in-
teractions between residues Ile332 and
Met335 in PME-1 and residues His59,
Leu243, and Phe260 in the C subunit. Of
these residues, His59 was shown to
bind to metal ions in the active site of
the PP2A core enzyme (Xing et al., 2006).
In the periphery of the interface, two H-bond networks stabi-
lize both ends of the S-shaped interface. In one network, three
H-bonds were formed between Arg268 of the C subunit and
several residues at the amino terminus of helix a9 in PME-1
(Figure 3B). In the other network, a water molecule mediates hy-
drogen bonds among residue 213 in the C subunit and the side
chains of Gln340, Arg369, and His370 in PME-1. Arg369 forms
an additional hydrogen bond to residue 212 of the C subunit.
To corroborate these structural observations, we performed
a mutational analysis on PME-1 (Figure S2). We generated three
missense mutations in PME-1 and assayed their impact on the
methylesterase activity of PME-1. Because these mutations do
not involve residues at the active site of PME-1, a decrease in
the methylesterase activity likely reflects a weakened binding
affinity between PP2A and the specific PME-1 mutant. In the
structure, the side chain of Arg369 participates in multiple inter-
molecular hydrogen bonds with PP2A; thus its mutation to Asp is
expected to reduce the binding affinity between PME-1 and
PP2A. Consistent with this prediction, R369D in PME-1
resulted in marked reduction of its methylesterase activity (Fig-
ure S2). In contrast, the side chains of Gln334 and Gln336 in
PME-1 are not involved in any interaction with PP2A; their muta-
tions are predicted not to affect the PME-1–PP2A interaction and
thus had no effect on the methylesterase activity (Figure S2).Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc. 157
Recognition of Substrate by PME-1
The carboxy-terminal residues of the C subunit bind to the active
site pocket of PME-1 (Figure 4A). The interface contains exten-
sive van der Waals contacts, with three intermolecular H-bonds
contributing to the specificity of recognition. Collectively, these
interactions result in the burial of approximately 1130 A˚2 ex-
posed surface area.
On one side of the active site pocket, the side chains of Tyr307
and Leu309 in the C subunit are nestled in a hydrophobic groove
formed by six residues in the cap domain of PME-1: Met194,
Phe197, and Leu198 in helix a4 and Leu291, Trp298, and
Trp301 in helix a7 (Figure 4A). On the other side of the pocket,
a network of H-bonds stabilizes the conformation of the catalytic
triad and helps coordinate the substrate (Figure 4A). These
H-bonds involve residuesArg325,Asp181,and His349,backbone
amides of residues 85 and 157 of PME-1, and the carboxylate
group of Leu309 in the C subunit. In particular, Asp181 accepts
an H-bond from His349. Ala156, which corresponds to the cata-
lytic residue Ser156, is located close to the carboxylate group of
Leu309 and within close proximity of His349 in PME-1. These ob-
servations suggest that, in contrast to free PME-1, the active site
residues in the PP2A-bound PME-1 may exist in an active confor-
mation, poised to catalyze the bound substrate.
Activation of PME-1
Structural comparison between free PME-1 and the PP2A-
bound PME-1 reveals that the substrate peptide would overlap
significantly with helix a4 of the free PME-1 (Figure 4B). This anal-
ysis explains why free PME-1 does not bind to the isolated car-
Figure 3. Interface between PME-1 and the C Subunit
of the PP2A Core Enzyme
(A) PME-1 and the C subunit form an S-shaped interface. A
slice of the complex is shown.
(B) A close-up view of the interface in stereo. Residues from
PME-1 and the C subunit are shown in green and magenta,
respectively. H-bonds are represented by dotted lines.
boxyl-methylated peptide TPDYFL309 of the C sub-
unit. This observation, together with the inactive
conformation of the catalytic triad residues in free
PME-1, also explains why free PME-1 exhibits no
detectable methylesterase activity for the isolated
peptide substrate (Lee et al., 1996).
The interactions between PME-1 and PP2A result
in two striking consequences. The first conse-
quence is the activation of PME-1. The specific in-
teractions between PME-1 and the C subunit induce
marked conformational rearrangements surround-
ing the active site region of PME-1, resulting in its
activation (Figure 4C). In particular, extensive inter-
actions of helix a9 in PME-1 with the C subunit
cause a9 to shift toward helix a4, which forces a4
to bend (Figure 4B). These structural changes result
in the widening of the active site pocket in PME-1
that accommodates the substrate peptide. These
changes also cause the catalytic triad residues to
rearrange into an active conformation (Figure 4C). Remarkably,
the side chain of His349 swings approximately 8 A˚ to hydrogen
bond with Asp181 and to be within H-bond distance of the cata-
lytic residue 156. The carboxylate group of Leu309 in the sub-
strate peptide is in close proximity to the catalytic residue and
in an appropriate orientation for catalysis. Corroborating these
structural observations, PME-1 was only inactivated by PMSF af-
ter PME-1 was preincubated with a PP2A core enzyme involving
truncation of the carboxyl terminus of the catalytic subunit
(Figure S3).
Our structural analysis identifies Ser156, His349, and Asp181
as the catalytic triad residues. Consistent with this analysis, mu-
tation of Ser156 or His349 to Ala abolished the methylesterase
activity, whereas mutation of Asp181 markedly reduced the es-
terase activity by 75% or more (Figure 4D). In contrast, mutations
of other histidine and aspartate residues near the active site have
much less impact on the esterase activity of PME-1 (Figure 4D).
Inactivation of PP2A by PME-1
The second striking consequence following binding of PME-1 to
the PP2A core enzyme is the displacement of the metal ions from
the active site of the C subunit (Figure 5A). The two manganese
atoms in the C subunit of the PP2A core enzyme were dislodged
and gone in the PP2A–PME-1 complex. Consequently, the PP2A
core enzyme is inactivated by PME-1.
Met335 in PME-1, a hydrophobic amino acid highly conserved
in other PME orthologs (Figure 1B), appears to play an important
role in displacing the metal atoms. Comparison with the structure
of the PP2A core enzyme reveals that the side chain of Met335158 Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc.
penetrates deeper into the active site of the C subunit than the
acidic head group of okadaic acid (Figure 5B). The hydrophobic
nature of Met335 may also discourage the reloading of metal ions
into the active site. Consistent with this interpretation, mutation
of Met335 to aspartate in PME-1 led to decreased ability to
remove the metal ions, and the PP2A–PME-1–M335D complex
became readily activated by manganese (Figure S4). Supporting
our structural observation, an inactive population of PP2A was
previously shown to be stably associated with PME-1 in cells
that could not be activated by manganese (Longin et al., 2004).
DISCUSSION
Despite intense study of PME-1 in the last decade, the mech-
anisms of substrate binding, catalysis, and function remained
enigmatic. Our structural analysis of PME-1 by itself and in
complex with PP2A showed that PME-1 is only activated
upon binding to PP2A. This property ensures the specificity
Figure 4. Activation of PME-1
(A) Recognition of the carboxy-terminal peptide of the C
subunit by PME-1. In this stereo view, 2Fo-Fc electron
density is shown at 1.5s level around the peptide (ma-
genta). H-bonds are represented by dotted lines.
(B) Structural comparison of free PME-1 (cyan) and the
PP2A-bound PME-1 (yellow). Only regions around the
active site of PME-1 are shown. The carboxy-terminal
peptide of the C subunit is shown in magenta.
(C) Stereo view of the conformational changes at the
active site.
(D) Mutation of the catalytic triad residues resulted in
marked reduction of the methylesterase activity of PME-1.
of the PME-1-associated methylesterase
activity for PP2A. Activation of PME-1 entails
two major conformational rearrangements:
opening of the active site pocket through
bending of helix a4 and alignment of the cat-
alytic triad residues into an active conforma-
tion. These observations provide a satisfactory
explanation to the questions of why a synthetic
peptide alone could not be the substrate
or inhibitor of PME-1 (Lee et al., 1996) and
why the esterase activity could not be
inhibited by PMSF treatment. The structural
observation that PME-1 binds directly to the
PP2A active site, overlapping the binding sites
for phosphatase inhibitors okadaic acid and
microcystin-LR, explains why these inhibitors
blocked the methylesterase activity of PME-1
(Lee et al., 1996).
Our structural observation clearly indicates
that PME-1 inactivates the phosphatase activity
of PP2A. However, previous studies showed
that serine/threonine phosphatase activity of
PP2A could not be blocked by PME-1 (Longin
et al., 2004). How to reconcile the contrasting
observations? We believe that these seemingly
conflicting observations reflect the kinetic nature of the metal
ion removal. Although binding of PME-1 to the PP2A core enzyme
occurs instantaneously, removal of the metal atoms takes time.
The PP2A core enzyme, upon initial incubation with various con-
centrations of PME-1, exhibited full phosphatase activity toward
the substrate phosphorylase a (Figure S5A). A prolonged incuba-
tion time was required for substantial loss of the phosphatase
activity in vitro (Figure S5B). It should be noted, however, that
these experiments were performed in the presence of 100 mM
manganese ion and the free metal ions may slow down the pro-
cess of PME-1-mediated metal removal from the catalytic sub-
unit of PP2A. In cells, the dislodged metal ions are presumably
swept up by metal-binding proteins and no longer available for
reloading into PP2A. This analysis suggests that metal binding
in PP2A may be regulated and subject to interference by other
cellular proteins. Interestingly, incubation of PP2A with EDTA re-
sulted in marked reduction of phosphatase activity, presumably
due to metal chelation (Figure S5B).Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc. 159
It is important to note that, because PME-1 does not bind to
the A subunit, PME-1 binding to the PP2A core enzyme is un-
likely to affect the interactions between the regulatory subunits
and the PP2A core enzyme. In other words, PME-1 is unlikely
to dissociate preassembled holoenzymes. Nonetheless, PME-1
might still be able to exert negative regulation on the preassem-
bled holoenzyme through removal of its catalytic metal ions
(Longin et al., 2004) (Figure 6).
Earlier experimental evidence showed that methylation of the
carboxyl terminus of the C subunit may play an important role in
the formation of PP2A holoenzymes (Bryant et al., 1999; Kloeker
et al., 1997; Tolstykh et al., 2000; Wei et al., 2001; Wu et al.,
2000; Yu et al., 2001). Recent observations suggest that methyla-
tion of the carboxy-terminal Leu309 in a conserved TPDYFL309
motif of the C subunit may enhance the affinity of the PP2A core
enzyme for some, but not all, regulatory subunits (Ikehara et al.,
2007; Xing et al., 2006; Xu et al., 2006). In particular, neither meth-
ylation of Leu309 in the C subunit nor its carboxy-terminal residues
was required for the assembly of the PP2A holoenzyme involving
the B0 regulatory subunits (Longin et al., 2007; Xu et al., 2006).
Thus, the physiological significance for the observed interactions
of the carboxyl terminus of the C subunit with the residues located
at the interface between the A and B0 subunits (Cho and Xu, 2006;
Xu et al., 2006) remains to be elucidated. It should be noted, how-
ever, that enhanced affinity only represents one strategy by which
methylation may facilitate assembly of the PP2A holoenzymes. Al-
ternatively, methylation could serve as a targeting signal to bring
together all components that are required for holoenzyme assem-
bly. Investigation of this hypothesis requires a separate study.
The biological significance of PME-1-mediated PP2A inactiva-
tion in cells remains to be investigated (Longin et al., 2004, 2008).
The interaction between PME-1 and PP2A is subject to regula-
Figure 5. Inactivation of PP2A by PME-1
(A) A stereo view of the PME-1-PP2A interface at the active
site region of the C subunit. 2Fo-Fc electron density is shown
at 1.5s level surrounding side chains of Met335 in PME-1 and
the residues that are involved in binding to metal atoms in the
C subunit.
(B) Structural overlay of the PME-1-PP2A interface with the
active site of the C subunit in the PP2A core enzyme. The C
subunit in the PP2A core enzyme is colored cyan, with the
side chains shown in gold. The two manganese metal atoms
and okadaic acid are colored gray.
tion by an array of other PP2A-binding factors, in-
cluding but not limited to LCMT1 and PTPA. The
opposing roles of PME-1 and PTPA might form
a regulatory circuit of PP2A inactivation and acti-
vation (Fellner et al., 2003; Longin et al., 2004),
presumably through metal removal and reloading.
Furthermore, the stable complex between PP2A
and PME-1 blocks LCMT1-catalyzed methylation
(data not shown). Deletion of PTPA homologs in
yeast, rrd1/rrd2, resulted in elevated levels of sta-
ble PP2A–PME-1 complexes, accompanied by
decreased methylation (Hombauer et al., 2007).
In this regard, our structure of the PP2A–PME-1
complex might represent an important intermediate of PP2A
biogenesis that could only be methylated after activation in
Figure 6. A Structure-Based Model of PME-1 Function in PP2A
Regulation
In this model, PME-1 has two roles: demethylation and inactivation of PP2A.160 Cell 133, 154–163, April 4, 2008 ª2008 Elsevier Inc.
cells (Hombauer et al., 2007). The dual roles of PME-1 in coun-
teracting the function of PTPA and LCTM1 provide a mecha-
nism for coupling PP2A activation with methylation. Our struc-
tural observations provide mechanistic insights into the
interplay among PP2A methylation, holoenzyme assembly,
and its activation.
EXPERIMENTAL PROCEDURES
Protein Preparation and Assembly of PP2A–PME-1 Complex
All constructs and point mutations were generated using a standard PCR-
based cloning strategy. Full-length PME1 (1–386) and all the mutants were
cloned in pET15b vector (Invitrogen) and were overexpressed at room temper-
ature in E. coli strain BL21(DE3). The soluble fraction of the E. coli cell lysate
was purified by the Ni-NTA resin (QIAGEN) to homogeneity and further frac-
tionated by ion-exchange chromatography (Source 15Q, Amersham). PME-1
with methionine residues replaced by selenium methionine was expressed
by growing the bacteria in a minimum medium containing selenium methionine
and purified in a similar way.
To facilitate crystallization of the PP2A–PME-1 complex, a PME-1 construct,
containing residues 39–238, a small linker ‘‘EGK,’’ and residues 284–376, was
made based on the crystal structure of PME-1, which reserves all the structural
moieties for the esterase activity and PP2A recognition. Cloning, expression,
and purification of the PP2A Aa subunit (ADN) and the Ca subunit followed sim-
ilar procedures to those described previously. The PP2A core enzyme, involv-
ing the full-length Ca and ADN, was assembled as described (Xing et al., 2006).
The PP2A core enzyme was methylated by a PP2A-specific leucine carboxyl
methyltransferase (LCMT1) in the presence of S-adenosyl methionine (SAM)
(see below). Following complete methylation, the PP2A core enzyme was incu-
bated with an excess amount of PME-1 containing an inactive mutation
(S156A). The PP2A–PME-1 complex was purified to homogeneity by gel-
filtration chromatography.
Limited Proteolysis of PME-1 and Characterization
of the PME-1 Enzyme Core
To facilitate crystallization of PME-1, a structural core of PME-1 was generated
by incubation of the full-length PME-1 with 0.5 mg/ml trypsin for 20 min on ice.
The enzyme core that contains two fragments of PME-1, 28 and 8 kDa (resi-
dues 39–248 and 273–386, respectively), was purified by the anion exchange
chromatography (Source 15Q, Amersham). Using the methylesterase activity
assay (see below), this PME-1 enzyme core exhibited a similar activity to
that of the full-length PME-1 (data not shown).
Crystallization and Data Collection
The diffracting crystals of the PME-1 enzyme core were grown at 4C by the
hanging-drop vapor-diffusion method by mixing the enzyme (15 mg/ml) with
an equal volume of reservoir solution containing 24%–26% Jeffamine-2001
(v/v), 200 mM sodium chloride, and 5 mM DTT. The crystals appeared after
1–2 days and reached a maximum size within one week. The crystals are in
the space group P3121, with unit cell parameters a = b = 82.5 A˚, c = 90.8 A˚,
a = b = 90, g = 120, and contain one protein molecule in each asymmetric
unit. The crystalswere equilibrated in a cryoprotectant buffer containing the res-
ervoir buffer with 34% (v/v) Jeffamine-2001 and were flash frozen in a cold nitro-
gen stream at 170C. A complete 2.0 A˚ native data set and a complete 2.6 A˚
seleno-methionine MAD dataset were collected at NSLS beamline X25 and pro-
cessed using the software Denzo and Scalepack (Otwinowski and Minor, 1997).
Diffracting crystals of the PP2A–PME-1 complex were grown at room tem-
perature by the hanging-drop vapor-diffusion method by mixing the protein
(6 mg/ml) with an equal volume of reservoir solution containing 23%–25%
PEG3350 (v/v), 100 mM ammonium citrate, and 5 mM DTT. The initial crystals
appeared after 5 days and were used for microseeding thereafter to facilitate
nucleation; and the crystals were grown to a maximum size in 2–5 days. The
crystals belong to the space group C2, with a = 129.3 A˚, b = 54.8 A˚, c =
125.2 A˚, a = 90, b = 111, g = 90, and contain one complex per asymmetric
unit. Crystals were equilibrated in a cryoprotectant buffer containing reservoir
buffer with 34% PEG3350 (v/v), 20% glycerol (v/v), and 50 mM MnCl2, followedby dehydration for 2 hr and flash freezing as described above. The native data-
sets were collected at NSLS beamline X29 and processed as described earlier.
Structure Determination
The structure of human PME-1 was determined by selenium MAD (Hendrickson
et al., 1988). Selenium atom locations and initial MAD phases were determined
using the SHELX program suite (Sheldrick, 1991), and phases were subse-
quently improved with the program SHARP to a maximum resolution of 2.6 A˚.
The experimental map was of sufficient quality that it was possible to automat-
ically build most of the structure using the program ARP/wARP (Perrakis et al.,
1999) using the MAD phases with the incorporation of the native data to 2.0 A˚
resolution. The refinement was subsequently completed using several rounds
of manualmodelbuilding using the program O (Jones et al., 1991) and the refine-
ment using program CNS (Brunger et al., 1998). The structure is refined to 2.1 A˚
resolution and free and working R factors are 21.9% and 18.2%, respectively.
The structure of human PP2A–PME-1 complex was determined by molecu-
lar replacement using three models: Ca (residues 6–293), Aawith heat repeats
11–15 (residues 400–589) from the structure of the PP2A core enzyme (acces-
sion code 2IE3) (Xing et al., 2006), and the structure of PME-1. The three pro-
teins in the complex were located using the program PHASER (McCoy et al.,
2005). Model building was performed using O (Jones et al., 1991) and refined
using REFMAC restraints with TLS (Winn et al., 2003), and weights were ad-
justed on the basis of Rfree. Three TLS groups were used, one for each subunit;
and the TLS parameters were refined in early cycles and remained the same
for later stage of refinements. The final atomic model of the PP2A–PME-1
complex has been refined to 2.8 A˚ resolution and free and working R factors
are 26.4% and 19.5%, respectively.
PME-1 Nethylesterase Activity Assay
The methylesterase activity of PME-1 and its mutants was tested by a cycled
methylation and demethylation assay. Briefly, radiolabeled 3H-SAM is mixed
with 7.2 mM PP2A core enzyme and 0.2 mM LCMT1 to generate methylated
PP2A. Release of H3-methanol was initiated by addition of the full-length
PME-1, mutants, or the PME-1 core. Concentration-dependent PME enzyme
activity was determined by the counts of H3-methanol after 2.5 hr or overnight
incubation of the reaction mixture at 37C.
Methylation of PP2A Core Enzyme by LCMT1
LCMT1 and PP2A core enzyme, at a 1:2 molar ratio, was incubated on ice.
Methylation was initiated by addition of SAM to a final concentration of
0.75 mM. The reaction was carried out at 30C and reached maximum after
1–2 hr. The methylated PP2A core enzyme was purified away from LCMT1
by anion exchange chromatography.
ACCESSION NUMBERS
The atomic coordinates of PME by itself and in complex with PP2A have been
deposited in the Protein Data Bank with the accession codes 3C5V and 3C5W,
respectively.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
at http://www.cell.com/cgi/content/full/133/1/154/DC1/.
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